Loeb S, Roehl KA, Helfand BT, Kan D, and Catalona WJ. “Can PSA Velocity Thresholds Reduce the Detection of Insignificant Prostate Cancer?” Journal of Urology 2010; 183: 112. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140466/
Loeb S, Roehl KA, Helfand BT, Kan D, and Catalona WJ. “Can PSA Velocity Thresholds Reduce the Detection of Insignificant Prostate Cancer?” Journal of Urology 2010; 183: 112. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140466/
Kettermann AE, Ferrucci L, Trock BJ, Metter EJ, Loeb S and Carter HB. “Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.” BJU International 2010 epub. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928882/
Loeb S and Catalona WJ “Prostate-specific antigen screening: pro.” Current Opinion in Urology, May 2010; 20: 185. Link: http://www.ncbi.nlm.nih.gov/pubmed/20224413
Loeb S, Montorsi F, Catto JW. “Future-Proofing Gleason Grading: What to Call Gleason 6 Prostate Cancer?” European Urology 2015 epub. PMID: 25769986. Link: http://www.ncbi.nlm.nih.gov/pubmed/25769986
Loeb S. “An Examination of the Dynamic Changes in Prostate-Specific Antigen Occurring in a Population-Based Cohort of Men Over Time.” BJU International August 2012; 110: 381-2. PMID: 22313542. Link: http://www.ncbi.nlm.nih.gov/pubmed/22313542
Loeb S and Catalona WJ. “Prostate Cancer: Utility of the Riskindicator Model in Screening.” Nature Reviews Urology, April 2010; 7: 184. Link: http://www.ncbi.nlm.nih.gov/pubmed/20383184
Loeb S. “Editorial comment re: Longitudinal Changes of Benign Prostate-Specific Antigen and [-2]ProProstate-Specific Antigen in Seven Years in a Community-Based Sample of Men.” Urology, March 2012; 79: 661. PMID: 22386421. Link: http://www.ncbi.nlm.nih.gov/pubmed/22386421
Loeb S. Editorial comment re: “Prostate Specific Antigen Velocity per Prostate Volume: A Novel Tool for Prostate Biopsy Prediction.” Urology 2011; 78: 879. PMID: 21982006 Link: http://www.ncbi.nlm.nih.gov/pubmed/21982006
Loeb S and Partin AW. “What is the true mortality benefit of prostate-specific antigen screening?” Reviews in Urology, Winter 2010; 12: 66. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859145/
Tel Aviv, Israel. July 2012 Lecture Topic: Prostate Cancer Screening Category: Prostate Cancer
Punta Cana, Dominican Republic. November 2013 Lectures Topics: PSA Screening, Prostate Cancer Markers, and Prostate Biopsy Complications Category: Prostate Cancer
Amsterdam, Netherlands. February 2014 Lecture topic: Risk based prediction models for indolent Prostate Cancer Category: Prostate Cancer
Moscow, Russia. March 2014 Lecture topic: PSA Screening Cost-Effectiveness, Prostate Cancer Markers Category: Prostate Cancer
San Jose, Costa Rica. August 2014 Lectures on: Active surveillance for prostate cancer, Highlights of the AUA meeting on Localized Prostate Cancer Category: Prostate Cancer
Manila, Philippines. September 2014 Lectures topic: Smarter PSA screening, Novel Prostate Cancer Markers, and Active Surveillance Category: Prostate Cancer
Rio de Janiero, Brazil. October 2014 Lecture Topic: Social Media in Medicine Category: Social media
Rome, Italy. February 2015 Lecture topic: PSA Screening Yes or No Category: Prostate Cancer
Florence, Italy. October 2014 Lecture Topic: Social Media in Urology Category: Social Media
Rome, Italy. April 2013 Lectures Topic: Nature vs Nurture in Prostate Cancer, and Prostate Specific Antigen Velocity Category: Prostate Cancer
Banks JA, McGuire BB, Loeb S, Shrestha S, Helfand BT, Catalona WJ. “Bacteriuria and antibiotic resistance in catheter urine specimens following radical prostatectomy.” Urologic Oncology 2012, epub Jan 25. PMID: 22285005. Link: http://www.ncbi.nlm.nih.gov/pubmed/22285005
Loeb S, Schaeffer EM, Chan DW, Carter HB, Walsh PC, and Sokoll LJ. “Investigation of Human Anti-Mouse Antibodies As Potential Cause of Postprostatectomy PSA Elevation.” Urology, May 2009; 73: 947. Link: http://www.ncbi.nlm.nih.gov/pubmed/19394489
Loeb S, Roehl KA, Viprikasit DP, and Catalona WJ. “Long-Term Rates of Undetectable PSA with Initial Observation and Delayed Salvage Radiotherapy after Radical Prostatectomy.” European Urology, July 2008; 54: 88. Link: http://www.ncbi.nlm.nih.gov/pubmed/18400368
Madrid, Spain. March 2015 Lecture Topics: Prognostic Factors in the Prostate Histology, Social Media Categories: Prostate Cancer, Social Media, Erectile Dysfunction
Loeb S, Feng Z, Ross A, Trock BJ, Humphreys EB, and Walsh PC. “Can We Stop Prostate Specific Antigen Testing 10 Years After Radical Prostatectomy?” Journal of Urology August 2011; 186: 500. PMID: 21679999. Link: http://www.ncbi.nlm.nih.gov/pubmed/21679999 Patients often ask whether it is necessary to continue PSA testing indefinitely after radical prostatectomy. In the Johns Hopkins… Read More
Loeb S, Makarov DV, Schaeffer EM, Humphreys EB, and Walsh PC. “Prostate-specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy.” Journal of Urology, July 2010; 184: 157. Link: http://www.ncbi.nlm.nih.gov/pubmed/20483148 In men with newly diagnosed prostate cancer, bone metastases are uncommon at PSA levels <20 ng/ml. However, after radical prostatectomy… Read More
Madrid, Spain. February 2014 Lecture topic: Smarter Prostate Cancer Screening Category: Prostate Cancer
Rotterdam, Netherlands. November 2010 Lecture Topic: Prostate Cancer Category: Prostate Cancer
Budapest, Hungary. March 2011 Lecture Topics: Debate on Active Surveillance, Panel on Controversies in Prostate Cancer Category: Prostate Cancer
Stockholm, Sweden. April 2014 Lecture Topic: Invited lecture on Standardizing Report and Outcome of Surgery in Prostate Cancer Category: Prostate Cancer
Hemavan, Sweden. January 2012 Lecture topic: Prostate Cancer Risk among immigrants to Sweden Category: Prostate Cancer
Loeb S, Bruinsma SM, Nicholson J, Briganti A, Pickles T, Kakehi Y, Carlsson SV, Roobol MJ. “Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification.” European Urology 2014 Oct epub. PMID: 25457014. Link: http://www.ncbi.nlm.nih.gov/pubmed/25457014 This systematic review examined the utility of markers, genetic factors and risk stratification for… Read More
Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ. “Association of [-2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer.” Journal of Urology October 2012; 188: 1131-6. PMID: 22901577. Link: http://www.ncbi.nlm.nih.gov/pubmed/22901577 Longitudinal measurements of the Prostate Health Index (phi)… Read More
Loeb S. Editorial comment on “Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum β-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy.” Urology 2015; 85: 21-2. PMID 25530360 Link: http://www.ncbi.nlm.nih.gov/pubmed/25530360
Loeb S. “Is Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Ready for ‘Prime Time’?” European Urology 2014 Nov epub. PMID: 25465339. Link: http://www.ncbi.nlm.nih.gov/pubmed/25465339
Loeb S. “Editorial comment on ‘Current Ability of Multiparametric Prostate MRI and Targeted Biopsy to Improve the Detection of Prostate Cancer’” Urology Practice 2014 May; 1: 20.
Loeb S. Editorial Comment on “Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.” Urology 2014; 84: 1006-7. PMID: 25443895. Link: http://www.ncbi.nlm.nih.gov/pubmed/25443895
Loeb S, Metter EJ, and Carter HB. “Re: An Empirical Evaluation of Guidelines on Prostate-Specific Antigen Velocity in Prostate Cancer Detection.” Journal of the National Cancer Institute November 2011; 103: 1636. PMID: 21926375. Link: http://www.ncbi.nlm.nih.gov/pubmed/21926375
Davuluri M, Loeb S. “Prevalence of Infections Associated with Prostate Biopsy.” Reviews in Urology 2014; 16: 156. PMID: 25337051. Link: http://www.ncbi.nlm.nih.gov/pubmed/25337051
Loeb S, Kettermann A, Carter HB, Metter EJ, Ferrucci L, and Walsh PC. “Prostate Volume Changes Over Time: Results From the Baltimore Longitudinal Study of Aging.” Journal of Urology 2009 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/19683305
Martin NE, Chen MH, Catalona WJ, Loeb S, Roehl KA, and D’Amico AV. “The Influence of Serial Prostate-Specific Antigen Screening on the PSA Velocity at Diagnosis.” Cancer, 2008; 113: 717. Link: http://www.ncbi.nlm.nih.gov/pubmed/18615505